SAN FRANCISCO, Dec. 29, 2020 /PRNewswire/ -- Invitae Corporation
(NYSE: NVTA), a leading medical genetics company, today announced
that Sean George, co-founder and
chief executive officer of Invitae, will present at the 39th Annual
J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. Eastern/7:50
a.m. Pacific. Following the company presentation, management
will participate in a virtual breakout session at 11:10 a.m. Eastern/8:10
a.m. Pacific.
The 2021 J.P. Morgan Healthcare Conference is being held
virtually via webinar. A live webcast of both the presentation and
the breakout session may be accessed at the following direct link
or by visiting the investors section of the company's website at
ir.invitae.com.
Public listeners can access an audio and slide recording of the
session, which will be available shortly after the conclusion of
the presentation and breakout session on the investors section of
the company's website at ir.invitae.com.
About Invitae
Invitae Corporation (NYSE: NVTA) is a
leading medical genetics company whose mission is to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people. Invitae's goal is to
aggregate the world's genetic tests into a single service with
higher quality, faster turnaround time, and lower prices. For more
information, visit the company's website at invitae.com.
Contact:
Laura D'Angelo
ir@invitae.com
(628) 213-3369
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invitae-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301198847.html
SOURCE Invitae Corporation